肌钙蛋白测量在颈动脉血运重建中的价值:范围综述
该系统综述检索截至2022年3月15日的文献,纳入4项研究共885例颈动脉内膜剥脱术或颈动脉支架置入术患者,总结围术期肌钙蛋白与心肌损伤、心肌梗死及主要不良心脏事件的关系。术后肌钙蛋白升高与长期不良心脏事件显著相关,但术前肌钙蛋白的预测价值及常规采样人群尚需进一步研究。
要点
- 术后肌钙蛋白升高发生率为11%至15.3%,与长期不良心脏事件显著相关。
- 术后30天内心肌梗死和主要不良心脏事件发生率为23.5%至40%。
- 术前肌钙蛋白的预测价值及常规采样人群尚需进一步研究。
核心结论
- 肌钙蛋白测量可能有助于预测不良心脏事件。
- 术前肌钙蛋白的预测作用、应常规采样肌钙蛋白的患者人群以及不同治疗方法/麻醉技术在颈动脉患者中的比较应进一步研究。
研究设计与样本
- 范围综述,系统检索MEDLINE和Web of Science截至2022年3月15日发表的英文研究。
- 纳入仅涉及颈动脉内膜剥脱术或颈动脉支架置入术患者、探讨围术期肌钙蛋白值与心肌损伤和/或心肌梗死和/或主要不良心脏事件及术后死亡率关系的研究。
- 由2名作者独立进行研究筛选,第三名研究者解决分歧。
- 共纳入4项研究,885例参与者。
主要发现
- 肌钙蛋白升高的风险因素包括年龄、慢性肾脏病、颈动脉疾病表现、闭合类型(直接闭合/静脉补片/涤纶补片/聚四氟乙烯补片)、冠状动脉疾病、慢性心力衰竭和长期使用钙通道阻滞剂。
- 肌钙蛋白升高发生率为11%至15.3%。
- 术后前30天内,心肌梗死和主要不良心脏事件发生率分别为23.5%至40%,即26.5%的肌钙蛋白升高患者发生。
- 术后肌钙蛋白水平升高与长期监测期间的不良心脏事件显著相关。
- 术后肌钙蛋白升高的患者心脏相关死亡率和全因死亡率更高。
临床怎么用
- 原文未据此给出推荐。
局限性
- 术前肌钙蛋白的预测作用、应常规采样肌钙蛋白的患者人群以及不同治疗方法/麻醉技术的比较应进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Patients undergoing carotid endarterectomy (CEA) or carotid artery stenting (CAS) are at substantially increased risk of short-term and long-term cardiac complications. Still, the role of perioperative troponin in predicting cardiac events remains unclear. The objective was to systematically summarize the existing evidence on the topic and provide directions for further research. MATERIALS AND METHODS: Studies that examined perioperative troponin values and its association with myocardial injury, and/or myocardial infarction (MI), and/or major adverse cardiac events (MACE) and postoperative mortality in exclusively CEA/CAS patients, published in English until March 15, 2022, were retrieved through a systematic search of MEDLINE and Web of Science. The study selection process was independently performed by 2 authors, while the third researcher resolved disagreements. RESULTS: Four studies with 885 participants met the inclusion criteria. Age, chronic kidney disease, presentation of carotid disease, type of closure (primary closure/venous patch/Dacron/polytetrafluoroethylene patch), coronary artery disease, chronic heart failure, and the long-term use of calcium channel blockers represent risk factors for troponin elevation, which occurred in 11% to 15.3%. Myocardial infarction and MACE occurred in 23.5% to 40%, that is, 26.5% of patients with troponin elevation, respectively, during the first 30 postoperative days. Elevated postoperative troponin levels were significantly associated with adverse cardiac events during the long-term surveillance period. The rates of cardiac-related and all-cause mortality were higher in patients with postoperative troponin elevation. CONCLUSION: Troponin measurement could be helpful in the prediction of adverse cardiac events. The predictive role of preoperative troponin, the patient population in whom routine troponin sampling should be used, and a comparison of different treatment methods/anesthesia techniques in carotid patients should be further examined.Clinical ImpactThe present scoping review critically appraises the extent and nature of the existing literature data on the predictive value of troponin on the occurrence of cardiac complications in patients undergoing CEA and CAS. In particular, it provides clinicians with essential insights by systematically summarizing the core evidence and identifying knowledge gaps that may direct future research. This, in turn, may significantly alter the current clinical practice and perhaps even reduce the incidence of cardiac complications in patients undergoing CEA/CAS.
引用
- Jovanovic K, Trailovic R, Jonsson M, et al. The Value of Troponin Measurement in Carotid Revascularization: A Scoping Review. J Endovasc Ther. 2023. PMID: 37287265. doi:10.1177/15266028231179874
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。